Limb Girdle Muscular Dystrophy: First Patient Dosed in Phase 2 Trial
According to a story from One News Page, the biopharmaceutical company BridgeBio Pharma and its affiliate ML Bio Solutions have recently announced that dosing has begun in its phase 2…